📢 Exeliom is thrilled to announce that we have been awarded a $500k grant from the Crohn's and Colitis Foundation!

With this funding, we're committed to advancing our EXL01 program, dedicated to maintaining remission in Crohn’s Disease without compromising on patient well-being.

The foundation is on a mission; to cure Crohn's disease and ulcerative colitis, and to improve the quality of life of children and adults affected by these diseases.

Huge thanks to them for their unwavering support! 🙌

🤔 Curious to learn more about our innovative EXL01 program?

Click below to discover Exeliom’s innovative technology and our mission!

https://www.exeliombio.com/pipeline/exl01-in-crohns-disease

‍